Mobasheri et al. suggest that curcumin could reach prophylactic properties by inhibiting NF‐κB signaling, thus preventing inflammation in osteoarthritis, and indicating that curcumin and resveratrol could be a candidate for adjuvant treatment with nonsteroidal anti‐inflammatory drugs27. This evidence concerns the gene NFKB1 and osteoarthritis.